Where Tech Meets Bio
Latest News
Paige and NHS Wales have launched a pilot project at Betsi Cadwaladr University Health Board (BCUHB) to evaluate the clinical utility of Paige PanCancer Detect—an …
Read More
Immunai and Parker Institute to Build Largest Single-Cell Dataset for Real-World Immunotherapy Research
Immunai and the Parker Institute for Cancer Immunotherapy (PICI) have announced a collaboration to build what they describe as the world’s largest patient-centric single-cell dataset …
Read More
Potato Lands $4.5M to Automate Lab Work with AI and Robots
Seattle-based startup Potato has raised $4.5 million in seed funding to accelerate development of its AI platform for automating scientific research. The company, founded in 2023 …
Read More
Latest News
Tempus, AstraZeneca, and Pathos Partner to Build Oncology Foundation Model Using Multimodal Data
GeneDx to Acquire Fabric Genomics to Enable AI-Powered, Decentralized Genome Interpretation
Elix and PRISM BioLab Partner to Tackle Hard-to-Drug Protein Targets with AI
Netherlands Outlines 2040 Biotech Vision, Emphasizing Tools, Commercialization, and Regulatory Reform
Sanger and PacBio Launch Long-Read Effort to Decode Immune Gene Activity
Finalists Announced for $10M Coller Dolittle Challenge on AI-Powered Interspecies Communication
Latest Insights
by Merlin Piscitelli
Cautious Optimism in 2024 for Healthcare M&A
2024 was supposed to mark the start of a significant comeback for healthcare mergers and acquisitions (M&A). Yet with the first half of the year …
Read More
by BiopharmaTrend
Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research
A new industry report from PicnicHealth reveals that nearly 80% of life sciences leaders are open to using virtual models to improve observational research, citing …
Read More
Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific
by BiopharmaTrend
Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research
by BiopharmaTrend
AI in Drug Safety: From Concept to Reality, The Industry's Path Forward
by Dr. Karthik Muthusamy
Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development
by Bea Mann, PhD
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
by Andreas Dreps, Bea Mann, PhD
The Future of Advanced Therapeutics: Opportunities and Challenges
by Sai Bhamidipati
What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025
by Megan Deegan
21 Life Science Marketplaces to Try in 2024
by Andrii Buvailo
From Our Partners
Sponsored by
Lantern Pharma
Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma
Sponsored by
RECEPTOR.AI
This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery
Sponsored by
Trialize
Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials
Sponsored by
Intelligencia AI
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Partner Events

The 12th Aging Research & Drug Discovery Meeting The 11th Aging Research & Drug Discovery Meeting
Event Date: Aug. 25, 2025 - Aug. 29, 2025
Location: Denmark (Ceremonial Hall, University of Copenhagen)
Website: Link

London Biotechnology Show 2025
Event Date: June 18, 2025 - June 19, 2025
Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)
Website: Link
Promo Code: 4CPHAK
Read more ›››

Global Clinical Trials Connect 2025
Promo Code: GCTC10 (valid till 2025-05-28)
Read more ›››
Case Studies
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Sponsored by
Cyclica
Cyclica's Chemical Probes for DCAF1
Sponsored by
Roivant Sciences
QUAISAR Computational Platform for Designing Targeted Protein Degraders
Sponsored by
Celeris Therapeutics
Application of AI-driven Xanthos Platform for Designing Protein Degraders
Sponsored by
RECEPTOR.AI
ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest
Sponsored by
Arctoris
Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery
Sponsored by
Science Exchange
How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange
Sponsored by
Bioz
Bioz Badges — Advanced Data-Widgets for Confident E-commerce
Interviews
[Interview] This Company Brings Quantum Tech Into Protein Design
Navigating Next Wave of Protein Design with Elise de Reus from Cradle
Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology
Cracking the Code of Life: An Interview with Stef van Grieken, CEO of Cradle, on AI-Driven Protein Engineering
Most Read
Insilico Medicine’s Generative AI Patent Provides Advantage in AI Drug Discovery Race
7 Promising RNA Biotech Companies To Watch in 2024
14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)
The Increasing Role of CROs in the Pharmaceutical Industry